Global Phosphodiesterase (PDE) Inhibitors Market 2019-2023| Rising Burden of Chronic Diseases to Boost Growth| Technavio

Technavio has announced its latest market research report titled global phosphodiesterase (PDE) inhibitors market 2019-2023. (Graphic: Business Wire)

LONDON--()--The global phosphodiesterase (PDE) inhibitors market is expected to post a CAGR close to 6% during the period 2019-2023, according to the latest market research report by Technavio.

A key factor driving the growth of the market is the rising prevalence of erectile dysfunction (ED). The etiology of ED can be attributed to multiple factors, such as diabetes mellitus, testosterone deficiency, prostate cancer, obesity, hypertension, and hyperlipidemia. In addition, the consumption of certain medicines and substance abuse can lead to ED. As most of these factors are related to lifestyle changes, the prevalence of ED is increasing globally. Rapid urbanization, and the inherent lifestyle changes, along with high stress at the workplace are rendering young men more susceptible to ED. Thus, the increase in the incidence of ED is expected to boost the adoption of PDE inhibitors during the forecast period.

As per Technavio, the rising burden of chronic diseases will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global phosphodiesterase (PDE) inhibitors market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global Phosphodiesterase (PDE) Inhibitors Market: Rising Burden of Chronic Diseases

Chronic diseases are among the leading causes of death and contribute to a significant portion of annual healthcare expenditure. Rising healthcare costs associated with chronic diseases such as heart disease, stroke, diabetes and prediabetes is expected to lead to an increase in the adoption of PDE5 inhibitors. Thus, an increase in the economic and health burden of these diseases will ensure continuous or increased use of PDE5 inhibitors for their remission, which will promote market growth during the forecast period.

“Apart from the rising burden of chronic diseases, the application of novel technologies for PDE inhibitors development and the growing geriatric population are two other major factors that are expected to boost market growth during the forecast period,” says a senior analyst at Technavio.

Global Phosphodiesterase (PDE) Inhibitors Market: Segmentation Analysis

This market research report segments the global phosphodiesterase (PDE) inhibitors market by application (oral, topical, other RoA) and geographical regions (North America, Europe, Asia, and ROW).

The North America region led the market in 2018, followed by Europe, Asia, ROW respectively. During the forecast period, the North American region is expected to maintain its dominance over the global market and register the highest incremental growth due to the presence of large pharmaceutical companies that offer both branded and generic POE inhibitors.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Release Summary

The global phosphodiesterase (PDE) inhibitors market is expected to post a CAGR close to 6% during 2019-2023, according to Technavio.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200